Philip Wiredu Addo is a PhD candidate at McGill University’s Macdonald Campus, where he specializes in optimizing postharvest technologies for medicinal plants, including cannabis and hops. His expertise lies in spectroscopy, particularly NMR, and his work contributes significantly to improving postharvest quality and efficiency in these sectors.

With a strong background in food science and technology from the Kwame Nkrumah University of Science and Technology in Ghana, Philip has a unique interdisciplinary approach, combining scientific research with practical applications in the chemical and food industries. He is also a quality assurance consultant for OMBA PEARL, where he advises on best practices for processing, packaging, and compliance with regulatory standards in Ghana.

Philip’s research and consultancy work are shaping the future of medicinal plant postharvest processes, making him a key figure in this evolving field.

André Zarcos Afonso is an agronomist with expertise in medicinal cannabis cultivation. He currently serves as the Cultivation Director at Belvedere Pharma Group, where he oversees cultivation processes and ensures compliance with industry standards such as GACP (Good Agricultural and Collection Practices). With over five years of experience in the medicinal cannabis sector, André has played a critical role in the certification processes and self-inspections, ensuring that operations adhere to the highest quality standards.

André is also pursuing a master's degree in Economics with a specialization in Economic Development at Universidade de Évora, reflecting his dedication to improving sustainability and efficiency within agricultural practices. He is passionate about the integration of sustainability in the cannabis industry and has contributed to thought leadership on this topic through various publications.

Sourab Agarwal is a trailblazer in India’s burgeoning medical cannabis industry. As the founder of HempCann Solutions and Vedi Herbals, he has been at the forefront of crafting herbal medicines and nutraceuticals, focusing on the therapeutic potential of cannabis. His deep-rooted passion for natural medicine and his commitment to advancing healthcare innovation have led to groundbreaking collaborations and research.

With an MSc in Management from Nottingham University Business School, Sourab has combined his business acumen with a passion for plant-based medicine. Under his leadership, HempCann has expanded its reach, becoming a trusted name in the industry. His work is not only revolutionizing healthcare in India but also positioning him as a thought leader in the global cannabis movement.

Marianne Bays, PhD, is a cannabis industry consultant, entrepreneur, and advocate with over 20 years of experience in corporate consulting. As a Founding Board Member and Vice President of the New Jersey CannaBusiness Association (NJCBA), Marianne has played a key role in shaping cannabis regulations and advocating for industry growth. She holds a PhD in Business from the City University of New York and has extensive expertise in organizational development, strategy, and IT management. Currently, she leads NEC Provisions, aiming to bring high-quality cannabis manufacturing to the Northeast US.

Nirit Bernstein stands as a leading figure in cannabis research, spearheading groundbreaking studies at the Volcani Center as a Professor and Senior Principle Researcher. With over three decades of dedicated scientific inquiry, her leadership of the Medical Cannabis Research Lab has positioned the Volcani Institute at the forefront of agricultural science in Israel. Her work, deeply rooted in plant physiology, agronomy, and biology, has significantly advanced the understanding of cannabis's medical applications, shaping the scientific community's approach to this complex field.

Educated at the University of California, Davis, and having conducted postdoctoral research at the University of Missouri, Columbia, Prof. Bernstein brings a wealth of knowledge and an international perspective to her research. Her contributions are not only pivotal in enhancing crop yield and efficiency but also in fostering sustainable agricultural practices globally. Her expertise is continually sought after by academic and governmental bodies, underscoring her status as a distinguished scholar and a visionary in cannabis science.

Dave Bow is a visionary entrepreneur with a strong focus on crafting premium cannabis products while driving industry development in Canada.

He operates multiple businesses, including restaurant franchises and a cannabis cultivation company.

Deeply involved in shaping Quebec’s cannabis industry through AQIC, promoting innovation, and ensuring sustainable growth.

Has expertise in leadership, business scaling, brand development, and supply chain expansion.

Regularly attends and speaks at international cannabis business events such as ICBC Berlin.

Regis G. Burton, QYL, Esq. is a recognized leader in cannabis policy and medicinal cannabis regulation in the Caribbean.

Plays a key role in developing and enforcing cannabis industry policies in Antigua and Barbuda.

Strong connections in governmental affairs, police oversight, and corporate development.

International management experience and a leadership background in both nonprofit and governmental sectors.

Jyotsnessh Chauhan is a PhD research scholar at AIIMS Rishikesh, specializing in the phytochemistry of Indian cannabis strains. With over five years of experience in forensic toxicology, Jyotsnessh has been contributing to the cannabis research community, focusing on understanding the complex biochemical properties of cannabis plants. His expertise spans both academic and practical knowledge in forensic toxicology, which he has honed through internships with organizations like Delhi Police and CBI Forensic Laboratory.

Throughout his career, Jyotsnessh has demonstrated a commitment to enhancing the understanding of cannabis and its potential applications. His work is particularly focused on the therapeutic properties of cannabis strains in India, and he is an advocate for expanding cannabis research to explore its medicinal benefits further.

Valentina María Degrave is a highly driven PhD student at the Universidad Nacional del Litoral, where her research focuses on the effects of cannabis oil on metabolic syndrome, particularly exploring its potential in addressing hepatic steatosis and oxidative stress. With a BSc in Nutrition and a profound passion for biological sciences, Valentina's research is breaking new ground in understanding the therapeutic potential of phytocannabinoids in metabolic disorders. She has made significant strides in her field, as evidenced by her numerous publications, including high-impact studies on the effects of full-spectrum cannabis oil in experimental models.

Valentina has actively contributed to the scientific community through her role as an Adjunct Assistant Professor, where she mentors and guides students in the areas of biochemistry and biological morphology. Her work has garnered recognition, with her research being a finalist at prestigious events such as ExpoCannabis 2023. An emerging leader in cannabis research, Valentina continuously pushes the boundaries of science, with her research offering transformative insights into the intersection of cannabis and metabolic health.

Cristina Dirlea is a passionate sales professional and educator within the cannabis industry, blending hands-on retail experience with business development expertise. With a background as a budtender and cannabis educator, Cristina honed her skills in B2B sales, becoming an Area Sales Manager for a Canadian licensed producer. She currently works in Inside Sales at Sensi Brands, where she manages multiple territories, executes sales strategies, and builds partnerships to drive revenue growth.

Cristina is also a science advisor for EduCanNation, a nonprofit focused on medical cannabis education, and serves as the EU sales representative for Peak Pharm Labs, a company dedicated to developing therapies for sexual health conditions. Her particular interests revolve around women's health, minor cannabinoids like CBG and THCV, and normalizing cannabis use.

Leonardo Dos Santos is an ambitious and driven student at Rhine-Waal University, pursuing a bachelor's degree in Biomedical Engineering with a deep focus on medical research. Currently, he is also a Research Intern at the Laboratory of Neuroproteomics at the Universidade Estadual de Campinas (UNICAMP), where he explores the neuroprotective effects of the Endocannabinoid System against oxidative stress in human astrocytes and neural stem cells through advanced proteomics techniques. His work in this emerging field is contributing to critical discoveries in neuroscience and cannabis research.

Leonardo has also gained international certification in medical cannabis prescription through the Green Flower Institute, making him an expert in the field. His diverse academic background includes significant research experience at Faculdade São Leopoldo Mandic, where he studied the role of PRDX-4 in multiple myeloma prognosis. His dedication to applying interdisciplinary scientific knowledge continues to shape his promising career in the intersection of neuroscience, medical cannabis, and biotechnology.

Jean-Michel DUMAS is an experienced pharmacist and an innovator in pharmaceutical research. He serves as the Scientific Director at YD Pharmaceuticals, overseeing research and development strategies focused on creating innovative pharmaceutical solutions, particularly in the field of medical cannabis. He also manages two pharmacy locations, SELAS Pharmacie de la Galerie and SELAS Pharmacie de la Colline, where he ensures the safe and effective delivery of medications and health advice to patients.

With over 15 years of professional experience, Jean-Michel combines practical expertise in pharmaceutical care with a passion for scientific innovation. His leadership extends to managing research teams and driving projects that focus on cutting-edge medical treatments. YD Pharmaceuticals has achieved high levels of European certification, including GACP and GMP for cannabis flower cultivation, reflecting his commitment to quality and safety in pharmaceutical production.

Jean-Stephane Dupervil is a recognized leader in pharmaceutical and cannabis manufacturing, quality assurance, and regulatory affairs.

Strong influence in cannabis policy, operations, and international trade.

Experienced in leading multi-national teams and working with government and regulatory bodies.

Active in non-profit cannabis associations advocating for industry-wide quality standards and market expansion.

Chad Esch is a seasoned Master Grower with over a decade of hands-on experience in the cannabis cultivation industry, blending expertise from recreational and medical sectors. Beginning his career in Humboldt, California, Chad absorbed advanced cultivation techniques from legacy growers, setting the stage for his later successes internationally. At SafriCanna in South Africa, he led operations to EU-GMP Part 1 certification, mastering the intricacies of large-scale, compliant cannabis production.

Chad's extensive background encompasses both the freer recreational and the stringent medical cannabis sectors, providing him with unique insights into all facets of cannabis cultivation. His current role at PharmaCrop Pty Ltd in Australia involves overseeing cultivation and production processes that aim for high quality and compliance, ensuring the company’s products meet rigorous global standards.

Katrina Ffrench is the Founder and Director of UNJUST C.I.C, a non-profit organization focused on addressing discriminatory practices, culture, and policies within UK policing and the broader criminal legal system. With a commitment to achieving racial equity and social justice, Katrina has been a passionate advocate for marginalized communities, working tirelessly to bring about meaningful change. She previously served as the CEO of StopWatch and Chair of the MOPAC Stop and Search Community Monitoring Network, roles in which she effectively engaged communities and challenged systemic injustices.

An experienced fundraiser and relationship builder, Katrina has successfully diversified and increased income streams while managing organizational growth. She has appeared on TV, radio, podcasts, and in print media to provide a critical voice on policing and racial equity. Katrina has also participated in panels and events with MPs, academics, and civil liberties activists, delivering keynote speeches and leading workshops to raise awareness and challenge the mainstream narrative around policing and racialized communities.

Elliot Friedman is the founder of KYND LLC, a design services company that specializes in intellectual property support, including patent illustration, 3D modeling, and product development. With a background in textile science and design from the University of Rhode Island, Elliot combines creativity with technical expertise, helping inventors transform their ideas into reality.

Elliot’s career includes over 17 years in luxury fashion retail, working with top brands like Stuart Weitzman, Ferragamo, and Balenciaga. During this time, he exceeded $1 million in annual net sales and consistently earned recognition for his outstanding performance. His experience extends to patent law, licensing, and product development, where he emphasizes innovation and global progress through thoughtful design.

A passionate advocate for rare diseases and the therapeutic benefits of cannabis, Elliot is committed to raising awareness about the medical potential of minor cannabinoids and educating others on the health benefits they offer.

Matthew Gates is a distinguished Integrated Pest Management (IPM) expert and the founder of Zenthanol Consulting, where he specializes in holistic, eco-conscious pest management solutions. With over a decade of experience, Matthew provides comprehensive support to growers worldwide, developing preventative and curative strategies that consider ecological, logistical, and crop-specific factors. His deep knowledge of entomology and plant pathology, combined with a hands-on approach, has made him a trusted consultant across diverse agricultural landscapes.

Matthew is an active contributor to the cannabis cultivation community, with affiliations to the Cannabis Horticultural Association and numerous publications in reputable journals such as SKUNK Magazine and High Times. His innovative research has been recognized through various symposia and public speaking engagements, where he shares his expertise on rare pests, sustainable cultivation practices, and the integration of IPM techniques. Matthew’s commitment to fostering knowledge and readiness in agriculture is reflected in his global influence as an educator, writer, and advisor.

Jodie Giesz-Ramsay, formerly known as Jodie Emery, is a renowned advocate for cannabis reform and civil liberties, highly recognized for her influential role in the global cannabis movement. Owning and operating multiple pioneering entities such as Cannabis Culture Magazine, Pot TV, and the innovative hemp-themed coffee shop Jodie’s Joint, she has become a central figure in promoting cannabis culture and education. Her establishments serve as crucial platforms for advocacy, education, and the normalization of cannabis, significantly impacting public perception and policy discussions.

Jodie’s activism extends beyond business; she has been a vocal participant in political campaigns, public demonstrations, and has faced legal challenges, all in the pursuit of cannabis legalization and civil reform. 

Carl Haffner is a dynamic entrepreneur with over 20 years of C-suite and board-level experience across the medical cannabis and security sectors. Renowned for his ability to lead complex projects, Carl has driven growth and transformation in regulated industries worldwide. His expertise spans GACP/EU GMP compliance, strategic development, and the integration of advanced technologies like IoT and AI into operational processes.

Dr. Arno Hazekamp is a distinguished expert in cannabis research, celebrated for advancing the medicinal applications and standardization of cannabis. His transformative work at Bedrocan as the head of Research and Development introduced groundbreaking scientific methods that revolutionized cannabis cultivation and processing, enhancing the consistency and efficacy of medicinal cannabis products.

Beyond the lab, Dr. Hazekamp is a fervent educator who leads masterclasses globally, teaching healthcare professionals, researchers, and policymakers about the critical need for standardized medicinal cannabis practices. As an independent consultant, he continues to shape the industry by guiding companies through product development, quality assurance, and clinical trials. Dr. Hazekamp's contributions have profoundly impacted scientific knowledge and regulatory standards, ensuring the safety and reliability of cannabis in medical therapy.

Sean is an industry veteran in cannabis legal publishing and a key content director in the sector.

His work with Cannabis Law Report and Cannabis Law Journal makes him highly influential in regulatory discussions and legal frameworks globally.

Based in Sydney, Australia, Sean has global expertise, with a background in legal publishing and a presence in the UK and US cannabis regulatory scene.

Dr. Joseph-Kevin Igwe, MD, MPH, is an Assistant Professor at Baylor College of Medicine, where he is renowned for integrating community-focused care with healthcare infrastructures through telehealth and data-driven solutions. His significant contributions to cardiovascular clinical trial diversity during his fellowship at Stanford University have helped shape health equity and patient care standards.

Dr. Igwe is a board-certified physician with extensive global experience, having served communities in Argentina, South Africa, and Nigeria. His work emphasizes not only clinical expertise but also a deep commitment to addressing health disparities, evidenced by his numerous publications on health policy and the impacts of diverse clinical trials.

Dr. Hunter Land is an esteemed leader in cannabinoid research and development, serving as the Vice President of Research & Development at CannMed Events. With over a decade of experience in the biotech and pharmaceutical industries, Dr. Land has spearheaded pivotal projects addressing the therapeutic potential of cannabinoids, contributing significantly to the advancement of cannabinoid-based medicine. His commitment to groundbreaking research is reflected in his leadership roles at the Biopharmaceutical Research Company and his position on the Scientific Advisory Board at Nalu Bio.

Dr. Land's work is deeply rooted in exploring the intersection of cannabinoid science and neurobiology, where he has contributed to numerous clinical trials and research initiatives focused on unmet medical needs. His dedication to scientific excellence and patient care is also demonstrated in his roles as Chief Scientific Officer at Neeka Health and as an Executive Board Member at Alterola Biotech. As an influential voice in the field, Dr. Land continues to advocate for evidence-based approaches in cannabis medicine, ensuring that therapeutic cannabinoids reach their full potential in treating various medical conditions.

Camila Moreno Lopes de Andrade is a promising scholar with a diverse background in biochemistry and plant biotechnology. Currently pursuing her PhD in Applied Botany at the Federal University of Lavras, Camila has made significant strides in the study of psychoactive plants, particularly Cannabis sativa. Her research focuses on the multiplication and callogenesis of cannabis, exploring its potential for medicinal use.

Her academic journey began at the Federal University of São João del-Rei, where she honed her skills in plant cell culture and biotechnological applications. Alongside her academic pursuits, Camila has practical experience in quality control, having worked in the brewing industry and in epidemiological surveillance during the COVID-19 pandemic. Her multifaceted experience underscores her expertise in both research and applied science, positioning her as a key figure in the evolving field of cannabis biotechnology.Her work not only contributes to advancing the understanding of cannabis’s medicinal properties but also supports sustainable plant-based biotechnological solutions in Brazil.

Julie Manlius is a leader in Caribbean cannabis education and innovation, focusing on market research, legal frameworks, and business empowerment.

Actively shaping the cannabis landscape in Guadeloupe and the Caribbean by providing resources, knowledge, and networking opportunities.

Has experience in customer service, patient care, and strategic consulting for cannabis businesses.

Runs a community-driven initiative combining wellness, food, and education on cannabis infusion and alternative consumption methods.

Passionate about advancing the legal cannabis industry in Guadeloupe and its integration into sustainable economic models.

Dr. Celine Nicole-de Groot is an accomplished Senior Plant Researcher at Philips LED Solutions, specializing in advanced horticultural lighting and plant science. With a career dedicated to exploring the intersection of biology, physics, and technology, she has made significant contributions to the fields of vertical farming, medical cannabis research, and controlled environment agriculture. Her research at Signify focuses on optimizing light recipes to enhance the growth, quality, and chemical composition of plants, particularly in medical cannabis and sustainable food production.

Dr. Nicole-de Groot has led several collaborative research programs, including partnerships with renowned institutions such as Wageningen University, where her work on innovative light solutions has set new standards in agricultural efficiency. Her expertise in light interaction with plants has been instrumental in developing sustainable farming practices, improving nutritional content, and extending the shelf life of crops. Respected for her multidisciplinary approach, she continues to influence the future of modern agriculture through her cutting-edge research and leadership.

Mitchell Osak is a globally recognized cannabis industry expert, consultant, writer, and speaker.

He has extensive experience in strategy, branding, pricing, and transformation consulting for cannabis firms.

Former Partner at MNP, leading cannabis advisory and consulting across North America.

Runs the Cannabis Management Review, providing exclusive cannabis business insights.

Frequent guest on major media platforms, including BNN, TVO, Global News, Financial Post, and Toronto Star.

Alessandra Moraes Pedrosa is an accomplished researcher and expert in the field of cannabis genetics, propagation, and extraction. With a Ph.D. in Biotechnology and a Master's degree in Pharmaceutical Sciences from the Universidade Federal de São João del-Rei, she has an extensive background in the study and application of natural products and cannabinoid production through in vitro cultivation of Cannabis sativa L. Alessandra's experience includes teaching roles at the Universidade Federal de São João Del-Rei and managerial positions in genetic and propagation management at ABRACE (Associação Brasileira de Apoio Cannabis Esperança), where she established agricultural best practices.

Currently, she works with Ease Labs Pharma in Brazil, focusing on the industrial production of cannabis extracts and purified products, as well as genetic selection and cultivation practices in Colombia. Her skills span from farm and nursery management to advanced analytical techniques such as high-efficiency liquid chromatography (HPLC), making her a key player in the advancement of cannabis science and production.

Alexandre Poulin, MSc, is a seasoned educator and a vibrant speaker with a profound passion for botany and terroir. His diverse expertise ranges from social equity and business to plant extraction and territorial development, reflecting his commitment to continuous learning and creative research. Alexandre's international experiences have sharpened his skills in developing rigorous processes for studying terpenes, cannabinoids, and phenolic compounds, aiming to enhance their medicinal effects.

Currently, as the Chief Innovation Officer at Gayonica and CEO of ATP, Alexandre is dedicated to advancing the global cannabis industry by focusing on wellness and socially responsible product development. His leadership extends to presiding over the Quebec Council of Edible Cannabis, where he advocates for educational initiatives and socially and ecologically responsible projects within the cannabis sector.

Alex Revich is a key player in the global cannabis industry, focusing on innovation, education, and international trade.

Experience in launching cannabis trade associations and helping Canadian businesses expand internationally.

Expert in networking, sponsorship acquisition, and creating high-value industry collaborations.

Regular speaker at International Cannabis Business Conferences (ICBC) and industry trade shows.

Advocates for emerging cannabis markets to leverage Canadian expertise for faster and more efficient industry development.

Brendon Roberts stands out as a top agribusiness voice, melding extensive knowledge in agriculture, botany, and multimedia with a focus on cannabis cultivation and horticulture. Educated at the University of Guelph, he leverages his background in plant sciences to push the boundaries of agricultural research and innovation. His professional journey is highlighted by roles in senior management, where he has propelled advancements in cannabis crop production, quality assurance, and facility operations across corporate Canada.

A passionate communicator and educator, Brendon has authored significant publications on cannabis, contributing to its understanding and acceptance in society. He actively engages with various stakeholders, including scientists, farmers, and industry partners, to enhance agri-food systems and plant medicine. His commitment to sustainable agriculture and plant sciences makes him a sought-after speaker and authority in the field, influencing developments in Canada and internationally.

Mike Samways is a key figure in cannabis investment and transaction advisory through Hyde Advisory & Investments Inc.

He specializes in buying and selling cultivation facilities, securing funding, and guiding cannabis firms through regulatory landscapes.

Works closely with investors, businesses, and policymakers to optimize cannabis-related mergers and acquisitions.

Extensive background in business development, real estate transactions, and corporate sales strategy.

Michael Sexton is a dedicated AgTech innovator, CEO, and founder with extensive experience in agricultural advancements and negotiation expertise. Passionate about transforming the way we interact with plants, Michael has led the way in cutting-edge research and agricultural technology, making significant contributions to the botanical sector. He has worked with prominent institutions, including Johns Hopkins, Harvard Medical School, and Primitiv Group, enhancing agricultural practices through partnerships, research facilities, and groundbreaking projects.

In addition to founding and leading Exotic Plant Food, LLC, Michael has served as a Senior Technical Advisor for Primitiv Group and is currently pursuing an M.B.A. at Harvard Business School. He continues to focus on project management, with a strong emphasis on innovation, cross-functional collaboration, and cultivating partnerships that challenge norms in the agricultural world. Michael's journey is also marked by his time in the U.S. Marine Corps, where he honed leadership skills that have greatly influenced his professional achievements.

Dr. Jordan Tishler is a distinguished medical professional with an extensive career in both emergency medicine and cannabinoid therapeutics. As the President of the Association of Cannabinoid Specialists, Dr. Tishler has become a leading advocate for advancing clinical best practices in cannabis medicine. He brings his Harvard Medical School training and decades of experience to the forefront of patient care, medical advocacy, and cannabis policy reform. His organization is committed to safeguarding patients by ensuring that cannabis treatments are integrated into medicine with the same rigor and precision as any other therapeutic modality.

In addition to his leadership role, Dr. Tishler is the founder and CEO of InhaleMD, where he focuses on using cannabinoid therapeutics to address a range of patient concerns, including stress management, insomnia, and human sexuality. His dedication to patient care extends beyond clinical practice as he educates lawmakers, business executives, and fellow physicians on the benefits and responsible use of medical cannabis. An engaging speaker and thought leader, Dr. Tishler is a sought-after consultant, corporate director, and expert witness.

Pierre has played a pioneering role in South Africa’s media and cannabis industry for over 25 years.

He is a key figure in South Africa's hemp and cannabis legalization efforts, contributing to government reports, investment funds, and consulting firms in the sector.

He has actively worked with Cannabis Development Council (CDC), Traditional Healers Organisation (THO), and African Cannabis Industry Association (ACIA).

As the founder of Baobab International, he focuses on financial services, compliance, project management, and investment for cannabis projects.

He holds an MBA from Henley Business School (UK) and multiple cannabis-related certifications, including a Master Certificate from the Cannabis Training University (CTU).

Daniela Vergara is a distinguished researcher and educator, renowned for her expertise in evolutionary biology, genomics, and cannabis science. Holding a Ph.D. from Indiana University Bloomington, she has cultivated a deep understanding of plant genetics and evolutionary processes. Daniela's career trajectory has positioned her at the intersection of science and education, where she leverages her skills in data analysis, public speaking, and genomics to advance the field of cannabis research.

Her work is driven by a passion for scientific discovery and a commitment to educating the next generation of scientists in the complex dynamics of plant evolution and cannabis cultivation. At Cornell University, she continues to influence the industry through pioneering research and impactful education, shaping the conversation around cannabis and plant science on a global scale.

Hope Wiseman stands as a pioneering force in the cannabis industry, holding the distinction of being the youngest Black woman to own a cannabis dispensary in the U.S. Through her leadership at Mary and Main, she has turned her dispensary into a community cornerstone in Prince George’s County, Maryland, prioritizing patient education and top-notch service.

Beyond business, Hope is a passionate advocate for social equity, working tirelessly to reform cannabis perceptions and legislation within the Black community. Her dynamic presence and eloquent advocacy have made her a prominent speaker and a role model, driving meaningful change and fostering inclusivity in the cannabis sector.